Meline David W 4
4 · Moderna, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Moderna, Inc.MRNA
Meline David W
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-03-01+6,415→ 6,415 totalExercise: $0.00→ Common Stock (6,415 underlying) - Award
Stock Option (Right to Buy)
2022-03-01+26,020→ 26,020 totalExercise: $149.52From: 2023-03-01Exp: 2032-03-01→ Common Stock (26,020 underlying)
Footnotes (2)
- [F1]25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
- [F2]25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.